1
|
Ferreira BL, Ferreira DP, Borges SF, Ferreira AM, Holanda FH, Ucella-Filho JGM, Cruz RAS, Birolli WG, Luque R, Ferreira IM. Diclofenac, ibuprofen, and paracetamol biodegradation: overconsumed non-steroidal anti-inflammatories drugs at COVID-19 pandemic. Front Microbiol 2023; 14:1207664. [PMID: 37965564 PMCID: PMC10642723 DOI: 10.3389/fmicb.2023.1207664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2023] [Accepted: 10/02/2023] [Indexed: 11/16/2023] Open
Abstract
The consumption of non-steroidal anti-inflammatory drugs (NSAIDs) have increased significantly in the last years (2020-2022), especially for patients in COVID-19 treatment. NSAIDs such as diclofenac, ibuprofen, and paracetamol are often available without restrictions, being employed without medical supervision for basic symptoms of inflammatory processes. Furthermore, these compounds are increasingly present in nature constituting complex mixtures discarded at domestic and hospital sewage/wastewater. Therefore, this review emphasizes the biodegradation of diclofenac, ibuprofen, and paracetamol by pure cultures or consortia of fungi and bacteria at in vitro, in situ, and ex situ processes. Considering the influence of different factors (inoculum dose, pH, temperature, co-factors, reaction time, and microbial isolation medium) relevant for the identification of highly efficient alternatives for pharmaceuticals decontamination, since biologically active micropollutants became a worldwide issue that should be carefully addressed. In addition, we present a quantitative bibliometric survey, which reinforces that the consumption of these drugs and consequently their impact on the environment goes beyond the epidemiological control of COVID-19.
Collapse
Affiliation(s)
- Beatriz L. Ferreira
- Biocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá, AP, Brazil
| | - Dionisia P. Ferreira
- Biocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá, AP, Brazil
| | - Swanny F. Borges
- Biocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá, AP, Brazil
| | - Adriana M. Ferreira
- Biocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá, AP, Brazil
| | - Fabricio H. Holanda
- Biocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá, AP, Brazil
| | - João G. M. Ucella-Filho
- Department of Forestry and Wood Sciences, Federal University of Espírito Santo, Jerônimo Monteiro, Espirito Santo, Brazil
| | - Rodrigo Alves S. Cruz
- Biocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá, AP, Brazil
| | - Willian G. Birolli
- Molecular Oncology Research Center, Institute of Learning and Research, Barretos Cancer Hospital, Barretos, SP, Brazil
| | - Rafael Luque
- Universidad ECOTEC, Via Principal Campus Ecotec, Samborondón, Ecuador
| | - Irlon M. Ferreira
- Biocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá, AP, Brazil
| |
Collapse
|
2
|
Abstract
Sperm granuloma and epididymitis remain 2 of the most common and incapacitating complications of vasectomy. A study was designed to evaluate the possibility of reducing these inflammatory complications with a prophylactic course of a nonsteroidal anti-inflammatory drug. Patients undergoing outpatient vasectomy were randomized into 2 groups. Group 1 received a prophylactic course of ibuprofen and group 2 received no medication. The ibuprofen was tolerated well and no adverse reactions were noted. There was no increase in postoperative bleeding or hematoma formation. There was no clinical benefit or decrease in complication rate in the ibuprofen-treated group.
Collapse
Affiliation(s)
- A L Manson
- Department of Urology, Naval Hospital, Great Lakes, Illinois
| |
Collapse
|